Literature DB >> 33499815

Factors for postoperative recurrence of orbital solitary fibrous tumor: an analysis of long-term clinical follow-up results from a Chinese tertiary hospital.

Peng Yang1, Hao-Cheng Liu1, E Qiu1, Wei Wang1, Jia-Liang Zhang1, Li-Bin Jiang2, Hong-Gang Liu3, Jun Kang4.   

Abstract

BACKGROUND: This study analyzed the clinical features, imaging manifestations, histopathology, immunohistochemistry, and surgical approaches of the orbital solitary fibrous tumor (OSFT), as well as the factors for postoperative recurrence of such disease.
METHODS: The clinical data of 16 patients with OSFT treated in our center from 2003 to 2020 were analyzed retrospectively, and the clinical symptoms, treatment methods, and follow-up results were recorded.
RESULTS: Of the 16 patients, 8 were females (50.0 %) and 8 were males (50.0 %); the average age of treatment was 37 ± 7 years and the median follow-up time was 74 (8, 228) months. Sixteen patients with OSFT underwent a total of 29 operations, of which 12 were transorbital approach operations and 17 were transfronto-orbital approach operations. Ten patients (10/16, 62.5 %) had recurrence. The recurrence rate of transorbital approach operations was 83.3 % (10/12), and the recurrence rate of transfronto-orbital approach operations was 17.6 % (3/17). No patients had treatment-related complications.
CONCLUSIONS: The main pathological feature of OSFT is a benign tumor. OSFT has a tendency to grow toward the cranio-orbital junction. The postoperative recurrence rate of OSFT is relatively high, so complete tumor resection is very important for prognosis. Inappropriate surgical approaches can lead to incomplete removal of the tumor and cause recurrence. Choosing the correct operation approach according to the position of the OSFT in the orbit and complete removal of the dura mater and bone affected by the tumor is crucial for the prognosis. Nevertheless, regular long-term follow-up after complete resection is necessary.

Entities:  

Keywords:  OSFT; Orbital; Surgical approach; Transfronto‐orbital; Transorbital

Mesh:

Year:  2021        PMID: 33499815      PMCID: PMC7839227          DOI: 10.1186/s12886-021-01825-6

Source DB:  PubMed          Journal:  BMC Ophthalmol        ISSN: 1471-2415            Impact factor:   2.209


  31 in total

Review 1.  Solitary fibrous tumor of the orbit: Case report and review of the literature.

Authors:  M T Koylu; G Ozge; Y Uysal; M S Deveci
Journal:  J Fr Ophtalmol       Date:  2017-03-15       Impact factor: 0.818

2.  Orbital solitary fibrous tumor: encompassing terminology for hemangiopericytoma, giant cell angiofibroma, and fibrous histiocytoma of the orbit: reappraisal of 41 cases.

Authors:  Emiko Furusato; Ives A Valenzuela; Julie C Fanburg-Smith; Aaron Auerbach; Bungo Furusato; J Douglas Cameron; Elisabeth J Rushing
Journal:  Hum Pathol       Date:  2010-11-05       Impact factor: 3.466

3.  Extrathoracic solitary fibrous tumors: their histological variability and potentially aggressive behavior.

Authors:  T Hasegawa; Y Matsuno; T Shimoda; F Hasegawa; T Sano; S Hirohashi
Journal:  Hum Pathol       Date:  1999-12       Impact factor: 3.466

4.  Head and neck solitary fibrous tumors: a rare and challenging entity.

Authors:  Julian Künzel; Michael Hainz; Thomas Ziebart; Susanne Pitz; Friedrich Ihler; Sebastian Strieth; Christoph Matthias
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-31       Impact factor: 2.503

5.  Myxoid solitary fibrous tumor: a study of seven cases with emphasis on differential diagnosis.

Authors:  N de Saint Aubain Somerhausen; B P Rubin; C D Fletcher
Journal:  Mod Pathol       Date:  1999-05       Impact factor: 7.842

Review 6.  Ocular adnexal (orbital) solitary fibrous tumor: nuclear STAT6 expression and literature review.

Authors:  Aleksandra Petrovic; Aurélie Obéric; Alexandre Moulin; Mehrad Hamedani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-13       Impact factor: 3.117

7.  Solitary fibrous tumor of the orbit: a case series.

Authors:  Eric S Tam; Edmund C Chen; Navdeep Nijhawan; John T Harvey; David Howarth; James H Oestreicher
Journal:  Orbit       Date:  2008

8.  Four cases of solitary fibrous tumour of the eye and orbit: one with sarcomatous transformation after radiotherapy and one in a 5-year-old child's eyelid.

Authors:  Stella Blandamura; Rita Alaggio; Giordana Bettini; Vincenza Guzzardo; Elisa Valentini; Alberto Bedogni
Journal:  J Clin Pathol       Date:  2013-10-09       Impact factor: 3.411

Review 9.  CD34 + tumours of the orbit including solitary fibrous tumours: a six-case series.

Authors:  Su Kyung Jung; Ji Sun Paik; Gyeong Sin Park; Suk-Woo Yang
Journal:  BMC Ophthalmol       Date:  2017-04-27       Impact factor: 2.209

10.  Solitary Fibrous Tumors of the Orbit and Central Nervous System: A Case Series Analysis.

Authors:  Marisa Brum; Hipólito Nzwalo; Edson Oliveira; Maria Rita Pelejão; Pedro Pereira; João Paulo Farias; José Pimentel
Journal:  Asian J Neurosurg       Date:  2018 Apr-Jun
View more
  4 in total

Review 1.  A review of solitary fibrous tumours of the orbit and ocular adnexa.

Authors:  Cornelius René; Paolo Scollo; Dominic O'Donovan
Journal:  Eye (Lond)       Date:  2022-07-13       Impact factor: 4.456

2.  Orbital solitary fibrous tumours: clinicopathological characteristics and recurrence prediction.

Authors:  Xiao-Jin Gao; Xiao-Lin Peng; Yu-Jiao Wang; Wei-Min He
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-08-27       Impact factor: 3.535

3.  Clinical characteristics and prognosis of orbital solitary fibrous tumor in patients from a Chinese tertiary eye hospital.

Authors:  Ming-Yu Ren; Jing Li; Yi-Xiang Wu; Rui-Miao Li; Chi Zhang; Li-Min Liu; Jing-Jing Wang; Yu Gao
Journal:  World J Clin Cases       Date:  2022-09-26       Impact factor: 1.534

4.  Orbital Solitary Fibrous Tumor: Four Case Reports-Clinical and Histopathological Features.

Authors:  Carmen Navarro-Perea; Cristina Calleja-García; Álvaro Bengoa-González; María-C Garrido; Enrique Mencía-Gutiérrez; Silvia Pérez-Trigo
Journal:  Case Rep Ophthalmol Med       Date:  2021-06-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.